• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Harpoon Medical launches mitral valve feasibility study

Harpoon Medical launches mitral valve feasibility study

September 15, 2015 By Fink Densford

Harpoon MedicalHarpoon Medical said it launched an early feasibility study of its minimally invasive mitral valve repair device, with aims to use the study to support CE Mark approval in the European Union.

The Baltimore, Md.-based company is developing a device to “transform the treatment of mitral regurgitation,” by eliminating the need perform an invasive breastbone separation and the use of a heart-lung machine during mitral valve procedures.

The technology it is developing could reduce the time required for mitral valve surgery from 3-6 hours to 60 minutes, according to Harpoon Medical.

“Conventional mitral valve surgery performed by a skilled surgeon is safe and effective, but it is an invasive procedure with significant morbidity. We developed the Harpoon device to address the demands of patients seeking a less invasive treatment option for mitral valve disease.  The early results have exceeded our initial expectations.  The Harpoon Medical approach achieves reduction of MR that is equivalent to open cardiac surgery with an outstanding safety profile and a dramatically less invasive procedure.  This is an extremely exciting technology that will transform the treatment of degenerative mitral valve disease,” founder Dr. James Gammie said in a press release.

Harpoon Medical said it enrolled 10 patients with severe degenerative mitral valve disease in the study at 2 European clinical sites.

The company said it plans to release the results, including over 850 implant days and ECG data on the 1st 2 patients, at an upcoming conference in October.

“I am very excited about the progress we have made since forming the Harpoon Medical a little over 2 years ago. Based on the company’s progress and the initial results from the Early Feasibility Study, our current investors are providing additional capital to accelerate the clinical program while we work to raise a larger Series B Round,” CEO Bill Niland said in a press release.

The company said it received a $1.4 million investment of convertible debt as part of a $2 million bridge expected to complete before the end of the month.

Last September, Harpoon Medical raised $3.8 million in a Series A funding round in support of its mitral repair devices. Financing was led by Epidarex Capital and joined by Maryland Venture Fund, the Abell Foundation and “medical device executives, doctors and successful business executives in the Maryland area,” Harpoon said.

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials Tagged With: Harpoon Medical

More recent news

  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy